Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

NCT02910102 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Dementia With Lewy Bodies
Parkinson's Disease Dementia

Interventions

DRUG: RVT-101 35 mg
DRUG: Placebo

Sponsor

Axovant Sciences Ltd.